Insecticides Intrinsic Value
Insecticides (INSECTICID) median intrinsic value is ₹300.92 from 8 valuation models (range ₹185–₹476), vs current price ₹616.10 — -51.2% downside (Trading Above Calculated Value), margin of safety -100.0%. Read INSECTICID dividend track record for the complete payout history and dividend yield track record.
INSECTICID Valuation Methods Summary — DCF, Graham Number & P/E
Insecticides intrinsic value across 8 models vs current price ₹616.10 — upside/downside and value range per method. For current market price and key ratios, visit Insecticides screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹192.96 | ₹154.37 - ₹231.55 | -68.7% | EPS: ₹16.08, Sector P/E: 12x |
| Book Value Method | asset | ₹420.69 | ₹378.62 - ₹462.76 | -31.7% | Book Value/Share: ₹420.69, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹475.59 | ₹428.03 - ₹523.15 | -22.8% | Revenue/Share: ₹594.48, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹248.28 | ₹223.45 - ₹273.11 | -59.7% | EBITDA: ₹120.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹300.92 | ₹240.74 - ₹361.10 | -51.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹184.83 | ₹166.35 - ₹203.31 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹184.83 | ₹166.35 - ₹203.31 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹390.14 | ₹351.13 - ₹429.15 | -36.7% | EPS: ₹16.08, BVPS: ₹420.69 |
INSECTICID Intrinsic Value vs Market Price — All Valuation Models
Insecticides fair value range ₹185–₹476 vs current market price ₹616.10 across 8 valuation models. Analyse INSECTICID shareholder distribution to track promoter, FII and institutional holdings.
INSECTICID Intrinsic Value Analysis — Undervalued or Overvalued?
Insecticides median intrinsic value ₹300.92, current price ₹616.10 — Trading Above Calculated Value by 51.2%, margin of safety -100.0%.
What is the intrinsic value of INSECTICID?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Insecticides (INSECTICID) is ₹300.92 (median value). With the current market price of ₹616.10, this represents a -51.2% variance from our estimated fair value.
The valuation range spans from ₹184.83 to ₹475.59, indicating ₹184.83 - ₹475.59.
Is INSECTICID undervalued or overvalued?
Based on our multi-method analysis, Insecticides (INSECTICID) appears to be trading above calculated value by approximately 51.2%.
INSECTICID Financial Health — Key Ratios vs Industry Benchmarks
Insecticides financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 37.13 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.86x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INSECTICID Cash Flow Quality — Operating & Free Cash Flow
Insecticides operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹94 Cr | ₹75 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹187 Cr | ₹164 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-54 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹135 Cr | ₹135 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹155 Cr | ₹99 Cr | Positive Free Cash Flow | 8/10 |